Downregulated miR-129-5p expression inhibits rat pulmonary fibrosis by upregulating STAT1 gene expression in

Qingzeng Qian1, Qinghua Ma2, Bin Wang3

  • 1School of Public Health, North China University of Science and Technology, Tangshan 063210, Hebei, China.

Abstract

Insights

MicroRNA-129-5p (miR-129-5p) carried by M2 macrophage exosomes inhibits pulmonary fibrosis by downregulating STAT1. Downregulating miR-129-5p promotes STAT1 expression, thus inhibiting lung fibrosis in rats.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Pulmonary Medicine

Background:

  • Pulmonary fibrosis is a chronic lung disease characterized by excessive extracellular matrix deposition.
  • The role of microRNAs (miRNAs) in regulating macrophage function and their impact on fibrotic diseases is an area of active investigation.
  • Signal transducer and activator of transcription 1 (STAT1) is a transcription factor implicated in inflammatory and fibrotic processes.

Purpose of the Study:

  • To elucidate the mechanism by which microRNA-129-5p (miR-129-5p) in macrophages influences pulmonary fibrosis in rats.
  • To investigate the regulatory relationship between miR-129-5p and the signal transducer and activator of transcription 1 (STAT1) gene in the context of pulmonary fibrosis.
  • To determine the role of M2 macrophage-derived exosomes in the intercellular transfer of miR-129-5p and its effect on pulmonary fibroblasts.

Main Methods:

  • Establishment of a rat model of pulmonary fibrosis.
  • Quantitative real-time polymerase chain reaction (qRT-PCR) to measure miR-129-5p and STAT1 expression.
  • Dual luciferase reporter assay to confirm the binding sites between miR-129-5p and STAT1.
  • Western blot analysis to assess protein expression levels.
  • Isolation and induction of M2 macrophages, followed by exosome extraction and characterization.
  • In vitro cell proliferation assays (EdU) and co-culture experiments with M2 macrophage-derived exosomes.
  • Histological analysis (Masson staining) and immunohistochemistry for fibrotic markers (α-SMA, COL-I).

Main Results:

  • miR-129-5p expression was significantly upregulated in the pulmonary fibrosis model group compared to the sham group.
  • miR-129-5p was confirmed to negatively regulate STAT1 expression.
  • Inhibition of miR-129-5p in vitro led to increased STAT1 expression, reduced fibroblast proliferation, and ameliorated pulmonary fibrosis.
  • M2 macrophage-secreted exosomes were shown to carry miR-129-5p and transfer it to pulmonary fibroblasts, increasing fibroblast proliferation and extracellular matrix production (COL1A2, COL3A1, fibronectin, α-SMA).
  • In vivo experiments confirmed that M2 macrophage exosomes carrying miR-129-5p could regulate pulmonary fibrosis.

Conclusions:

  • M2 macrophages can transfer miR-129-5p via exosomes to pulmonary interstitial fibroblasts, inhibiting STAT1 expression and promoting fibroblast proliferation, thereby exacerbating pulmonary fibrosis.
  • Downregulation of miR-129-5p in macrophages can enhance STAT1 gene expression, offering a potential therapeutic strategy to inhibit pulmonary fibrosis in rats.